Navigation Links
New Report Analyzes Key Controversies in Multiple Sclerosis Treatment
Date:11/14/2007

SCOTTSDALE, Ariz., Nov. 14 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for MS therapies.

In this report, entitled "MedPredict Thought Leader Insight & Analysis: Multiple Sclerosis," physician experts discuss the key controversies emerging from ECTRIMS (European Committee for Treatment and Research in MS) 2007, including:

-- Early aggressive therapy vs. more conservative approaches.

-- The negative results from REGARD, and implications for the powering of

MS trials. The report offers predictions on results expected in the

BEYOND, PreCISe and OLYMPUS.

-- The potential for pulmonary delivery of interferon and Copaxone.

-- The numerous orally available drugs in development for MS. The report

reviews the benefits and drawbacks of fingolimod, other S1Ps,

short-acting VLA4, teriflunomide, laquinimod, fampridine, fumarates and

other oral options, and predicts where they will fall on the

safety/efficacy spectrum.

-- The status and potential of a number of vaccine approaches.

-- Intriguing neuroprotection / neuroregeneration strategies, including

LINGO, anti-myelin-associated-glycoprotein MAb and remyelination MAb.

Drugs/Mechanisms mentioned in this report include: S1P agonists (fingolimod; Novartis, S1P1; Roche/Actelion, Sphingomab; Lpath, S1P1 modulators; Epix / Amgen), inhibitors of DNA synthesis/repair (teriflunomide; Sanofi-Aventis, cladribine; Ivax/Serono), potassium channel blockers (fampridine; Acorda, BNC-245; Bionomics), interferons (Avonex; Biogen, Rebif; Ares-Serono, Betaseron; Bayer-Schering and Biferonex; Biopartners Holdings), VLA4 inhibitors (Tysabri; Biogen/Elan, firategrast; GlaxoSmithKline, CDP-323; UCB/Biogen; ATL1102 (Antisense Th
'/>"/>

SOURCE MedPredict Market Research
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--deCODE,genetics,Inc...icefrom,theNasdaqStockMarketthattradinginthecompan...ndaForm25-NSEwillbefiledwiththe,SecuritiesandExcha...romlistingonNasdaq,unlessthecompanyfilesanappealto...filedsuchanappeal,which,willstaythesuspensionandde...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--deCODE,genetics,Inc...s,"firstday"motionsbytheU.S.BankruptcyCourtfortheD...tweekfiledavoluntarypetitionfor,reliefunderChapter...yCourt. , TheordersissuedbytheBankruptcyCourt...ngtheChapter11proceedings.Inparticular,the,company...
(Date:11/24/2009)...swire-Asia/--ShanghaiBiolaxyannouncedthe,ChineseSt...,investigationalnewdrugapplication(IND)foritsorali...iontotreatdiabetes.ThisIND,approvalallowsBiolaxyto...esisadisordercharacteristicofhighbloodglucoseandpo...tinseveremicro-and,macro-vasculardiseases,lossofvi...
(Date:11/24/2009)...nthasbeenmetforpatientswithadvanced-stage,orrecurr...ewswire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZ...companyfocusedonendocrinetherapyandoncology,todaya...stargetedcytotoxicpeptideconjugate,AEZS-108(former...rialcancer.Inapersonalizedhealthcareapproach,thest...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
..., Get Full-length cDNA , Ambio...V reverse transcriptase , to improve prod...e transcriptase, , <A , ...048">ArrayScript , (patent pending), pro..., cDNA than wild type RTs, and rivals even...
..., Screening with small interfering RNAs ,...d for identifying genes involved , ...the , effectiveness of two stra... siRNAs and transfection of pools of siRNAs--...eriments. The increased effectiveness of testing ,...
..., Isolate total RNA and protein from cul...ate nuclear and cytoplasmic RNA and protein from c...xtraction or alcohol precipitation , Am... based on , Ambion,s RNAqueous technology... from the same experimental sample. The kit also p...
Other Biology Technology:ArrayScript RT: Maximize Yields of Full-length cDNA 2ArrayScript RT: Maximize Yields of Full-length cDNA 3Are siRNA Pools Smart? 2Are siRNA Pools Smart? 3Are siRNA Pools Smart? 4Are siRNA Pools Smart? 5Are siRNA Pools Smart? 6Are siRNA Pools Smart? 7Are siRNA Pools Smart? 8Are siRNA Pools Smart? 9A Better Way to Isolate RNA AND Protein From the Same Sample 2A Better Way to Isolate RNA AND Protein From the Same Sample 3A Better Way to Isolate RNA AND Protein From the Same Sample 4A Better Way to Isolate RNA AND Protein From the Same Sample 5
(Date:11/24/2009)...UGE Antarctica has long held secrets of the earth...ently, there has been very little information on t...s of ice for millions of years. Now, a team of res...ve been funded to the tune of $10 million dollars ... to the bottom of things literally. These scienti...
(Date:11/23/2009)..., D.C. The community-associated strain of the dea...istant to most common antibioticsposes a far great...ng its way into hospitals, according to a study in...es . , The new threat is easily picked up in fi...d has increased the overall burden of MRSA within ...
(Date:11/23/2009)..., CT Current research suggests that a common oral... related report by Nichols et al, "Unique Lipids f... of TLR2 Ligands Capable of Enhancing Autoimmunity...ican Journal of Pathology . , Multiple sclerosis...he brain and spinal cord, affects nearly 1 in 700 ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 1RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 1Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 3Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 1Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 2Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 3
...ng paper from Drs. Hidenori Ichijo and Hideki Nish...s new and valuable insight into the genetics of AL...own as Lou Gehrig,s disease, is a rapidly progress...neration and death of motor neuron cells. , ALS ...orldwide, affecting as roughly 25,000 Americans, w...
...rch* shows that while engineered nanomaterials can...hain from single celled organisms to higher multic...low and there was no evidence of the nanomaterials...preliminary results observed by researchers from t...(NIST) suggest that the particular nanomaterials s...
...rporation has a public relations crisis, the news ...e world. According to new research in the Journal ...vokes judgments about the person and the situation...e crisis, and [our] research suggests that the fac...ion," say authors Gerald J. Gorn, Yuwei Jiang (bot...
Other Biology News:Research measures movement of nanomaterials in simple model food chain 2
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
...coli strain containing an overproducing clone of T... the formation of a phosphodiester bond between ju... duplex DNA or RNA. It repairs single-stranded nic...join both blunt-end and cohesive-end fragments of ...
Goat Anti-Pyruvate Kinase Polyclonal Antibody, Unconjugated from AbD Serotec
... essential component of the COP9 signalosome compl...nd developmental processes. The CSN complex is an ...tion pathway by mediating the deneddylation of the...The complex is also involved in phosphorylation of...
Biology Products: